Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q497M3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q497M3-F1 | Predicted | AlphaFoldDB |
26 variants for Q497M3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388502030 | 28 | C>Y | No | EVA | |
| rs3388507498 | 41 | A>G | No | EVA | |
| rs3388506201 | 43 | V>G | No | EVA | |
| rs3388508782 | 46 | T>I | No | EVA | |
| rs253908267 | 89 | S>T | No | EVA | |
| rs3388507479 | 93 | P>R | No | EVA | |
| rs3388506193 | 147 | V>F | No | EVA | |
| rs3388504108 | 151 | V>I | No | EVA | |
| rs230111729 | 163 | F>Y | No | EVA | |
| rs250059349 | 164 | P>T | No | EVA | |
| rs212292207 | 165 | T>S | No | EVA | |
| rs217018962 | 171 | K>E | No | EVA | |
| rs231770988 | 214 | I>T | No | EVA | |
| rs216012332 | 225 | T>A | No | EVA | |
| rs238207091 | 239 | T>I | No | EVA | |
| rs262687160 | 243 | L>P | No | EVA | |
| rs222829040 | 246 | Q>R | No | EVA | |
| rs237494742 | 265 | S>N | No | EVA | |
| rs3390795773 | 268 | P>L | No | EVA | |
| rs49502638 | 268 | P>T | No | EVA | |
| rs3390806094 | 288 | V>G | No | EVA | |
| rs260336369 | 295 | P>L | No | EVA | |
| rs245195728 | 325 | V>L | No | EVA | |
| rs265289824 | 327 | K>N | No | EVA | |
| rs229712670 | 342 | E>G | No | EVA | |
| rs31839828 | 343 | S>T | No | EVA |
No associated diseases with Q497M3
11 regional properties for Q497M3
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| repeat | Leucine-rich repeat | 93 - 114 | IPR001611-1 |
| repeat | Leucine-rich repeat | 116 - 174 | IPR001611-2 |
| repeat | Leucine-rich repeat, typical subtype | 91 - 114 | IPR003591-1 |
| repeat | Leucine-rich repeat, typical subtype | 115 - 138 | IPR003591-2 |
| repeat | Leucine-rich repeat, typical subtype | 139 - 162 | IPR003591-3 |
| repeat | Leucine-rich repeat, typical subtype | 163 - 186 | IPR003591-4 |
| repeat | Leucine-rich repeat, typical subtype | 190 - 214 | IPR003591-5 |
| domain | Immunoglobulin subtype 2 | 300 - 369 | IPR003598 |
| domain | Immunoglobulin subtype | 294 - 380 | IPR003599 |
| domain | Immunoglobulin-like domain | 302 - 378 | IPR007110 |
| domain | Immunoglobulin | 298 - 367 | IPR013151 |
No GO annotations of cellular component
| Name | Definition |
|---|---|
| No GO annotations for cellular component |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| hydrolase activity | Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. |
| metal ion binding | Binding to a metal ion. |
1 GO annotations of biological process
| Name | Definition |
|---|---|
| mRNA processing | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MEPLYEEILT | QGGTIVKPYY | WLSLSLGCTN | CPYHIRTGEE | ARVPYTEFHQ | TFGFPWSTYP |
| 70 | 80 | 90 | 100 | 110 | 120 |
| QTKHLTFYEL | RSSSKNLIQK | GLASNCTGSH | NHPEAMLFEK | NGYLDAVIFH | NSNIRHIILY |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SNNSPCNEAK | HCCISKMYNF | LMNYPEVTLS | VFFSQLYHTE | KQFPTSAWNR | KALQSLASLW |
| 190 | 200 | 210 | 220 | 230 | 240 |
| PQVTLSPICG | GLWHAILEKF | VSNISGSTVP | QPFIAGRILA | DRYNTYEINS | IIAAKPYFTD |
| 250 | 260 | 270 | 280 | 290 | 300 |
| GLLSRQKENQ | NREAWAAFEK | HPLGSAAPAQ | RQPTRGQDPR | TPAVLMLVSN | RDLPPIHVGS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| TPQKPRTVVR | HLNMLQLSSF | KVKDVKKPPS | GRPVEEVEVM | KESARSQKAN | KKNRSQWKKQ |
| 370 | |||||
| TLVIKPRICR | LLER |